Sumitomo Chemical India Ltd
Integrated Filing (Financial) for the quarter ended 30th June, 2026.
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 27 Jul 2026, 01:42 PM IST · BSE ID: 376120cb-f1b0-4ad2-8015-3207166dd4cf
View Original BSE Filing (PDF)
💡
In Simple Terms
Sumitomo Chemical India's Q1 FY27 standalone profit increased by over 20% on slightly higher sales.
🤖 AI Summary
- Standalone net profit for Q1 FY27 increased to ₹ 2,165.29 Million, up 20.42% from ₹ 1,798.06 Million in Q1 FY26.
- Standalone revenue from operations for Q1 FY27 stood at ₹ 10,540.75 Million, a 0.57% rise from ₹ 10,480.69 Million in Q1 FY26.
- Consolidated net profit for Q1 FY27 was ₹ 2,145.14 Million, an increase of 20.45% compared to ₹ 1,780.96 Million in Q1 FY26.
- Company received an insurance claim of ₹ 268.96 Million for business interruption from a FY22-23 fire incident.
- Profit before tax (after exceptional items) for Q1 FY27 standalone was ₹ 2,912.61 Million, up 20.41% YoY.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations
₹ 10,540.75 Million
0.57%
Standalone Profit for the year
₹ 2,165.29 Million
20.42%
Consolidated Revenue from operations
₹ 10,633.46 Million
0.62%
Consolidated Profit for the year
₹ 2,145.14 Million
20.45%
Standalone Basic and diluted EPS
₹ 4.34
🏢 How This Affects the Company
The minimal growth in standalone revenue from operations by 0.57% indicates stable sales volumes or pricing in the agro-chemicals segment, which is the company's only reportable segment.
Net profit growth of 20.42% standalone and 20.45% consolidated, partly aided by an exceptional insurance claim of ₹ 268.96 Million, positively impacts quarterly earnings. Cost of materials consumed increased by 24.25% YoY for standalone operations.
The receipt of an insurance claim for business interruption related to a past fire incident indicates resolution of a prior operational disruption, without further details on current plant capacity or workforce changes.
The ongoing legal challenge regarding the Central Government's Glyphosate notification introduces regulatory uncertainty, although its implementation is currently stayed by the Hon'ble Delhi High Court.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, with standalone earnings per share at ₹ 4.34 for Q1 FY27.
🔍
Management Signal
The financial results indicate management's focus on profitability, partly through resolving past insurance claims, and navigating regulatory challenges.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — monitor revenue and profit growth trends.
Updates on the Glyphosate notification legal challenge from the Hon'ble Delhi High Court.
Movement in cost of materials consumed to assess margin sustainability.
MEDIUM RISK
The ongoing regulatory uncertainty concerning Glyphosate, a key product, represents a material business risk.
💡 Investor Takeaway
Sumitomo Chemical India reported Q1 FY27 standalone net profit of ₹ 2,165.29 Million, up 20.42% YoY, and consolidated net profit of ₹ 2,145.14 Million, up 20.45% YoY. Revenue from operations for standalone was ₹ 10,540.75 Million, a 0.57% YoY increase.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Profit for the quarter ended 30 June 2026 increased 20.42% year-on-year to ₹ 2,165.29 Million.
- Consolidated Total Income for the quarter ended 30 June 2026 grew 1.38% year-on-year to ₹ 11,106.30 Million.
⚠️ Concerns
- Standalone Revenue from operations showed modest year-on-year growth of 0.57%, reaching ₹ 10,540.75 Million in Q1 FY27.
- Standalone Cost of materials consumed increased by 24.25% year-on-year to ₹ 5,493.47 Million, impacting gross margins.
📅 Company Track Record
In FY26, Sumitomo Chemical India's net profit increased by 8.21% YoY to ₹ 5,431.39 Million. The company accounted for an incremental impact of ₹ 151.86 Million in FY26 due to new labour codes as exceptional items.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Sumitomo Chemical India's standalone net profit for Q1 FY27?
Sumitomo Chemical India's standalone net profit for the quarter ended 30 June 2026 was ₹ 2,165.29 Million, an increase of 20.42% compared to Q1 FY26.
What was Sumitomo Chemical India's standalone revenue from operations in Q1 FY27?
Standalone revenue from operations for the quarter ended 30 June 2026 was ₹ 10,540.75 Million, reflecting a 0.57% increase from the same period in FY26.
What was the consolidated net profit for Sumitomo Chemical India in Q1 FY27?
The consolidated net profit for Sumitomo Chemical India for the quarter ended 30 June 2026 was ₹ 2,145.14 Million, representing a 20.45% increase year-on-year.
Did Sumitomo Chemical India receive any exceptional items in Q1 FY27?
Yes, Sumitomo Chemical India received an insurance claim for business interruption amounting to ₹ 268.96 Million, which was disclosed as an 'Exceptional Item' in Q1 FY27.
What is the status of the Glyphosate notification impacting Sumitomo Chemical India?
The Central Government's notification mandating Glyphosate use only through Pest Control Operators is not being implemented until the disposal of petitions challenging it before the Hon'ble Delhi High Court.
Questions based on this BSE filing only. For information purposes.